Inception 1
Latest round
- Series A
Last raised
- Jun 2014
Total raised
- $21M
Investors
- 1
About Inception 1
Inception 1 is a company focused on neurodegeneration for Alzheimer’s and other neurodegenerative diseases. It is translating biological insights into novel, first-in-class small molecule drugs for modifying diseases of aging.
Who invested in Inception 1
1 investor across 3 rounds
See all investors in Inception 1
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inception 1
Who invested in Inception 1?
Inception 1 has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inception 1 raised?
Inception 1 has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Inception 1 last raise money?
Inception 1's most recent round on record is a Series A, in Jun 2014.
What does Inception 1 do?
Inception 1 is a company focused on neurodegeneration for Alzheimer’s and other neurodegenerative diseases.
Where is Inception 1 headquartered?
Inception 1 is headquartered in San Diego, US.
Which VCs invest in companies like Inception 1?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inception 1's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Inception 1? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.